Milo Biotechnology Receives $250,000 New Funding Round

  • Feed Type
  • Date
  • Company Name
    Milo Biotechnology
  • Mailing Address
    Undisclosed Cleveland, OH 44101
  • Company Description
    Milo Biotechnology is a Cleveland-based company dedicated to improving the lives of patients with neuromuscular diseases. Milo’s early clinical stage follistatin program, exclusively licensed from Nationwide Children’s Hospital, is designed to increase muscle size and strength.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor

Trending on Xconomy